Management

Executive Officers

Bill Hoffman

Bill Hoffman

Chief Executive Officer
Bill has focused on early stage companies with novel devices in new markets. Prior to Inari Medical, Bill served as CEO of Visualase, Inc., which developed and sold lasers for minimally invasive neurosurgery. The company was acquired by Medtronic for $105M in July, 2014, having raised less than $10m in equity funding. Prior to Visualase, Bill was Vice President of Sales at FoxHollow, Inc., helping to build a commercial team and revenue ramp that led to a successful IPO in 2004 and an acquisition by EV3 in 2007. Bill’s first early stage med tech experience was as head of sales at RITA Medical Systems, an interventional oncology company that enjoyed a successful IPO in 2000. He spent the early part of his career in various sales roles at Ethicon and Medtronic.
Drew Hykes

Drew Hykes

Chief Operating Officer
Drew is a proven medical device operating executive with broad functional, geographic and sector experience. From 2012-2016 Drew served as the VP of Commercial Operations at Sequent Medical where he led the commercialization strategy for the WEB Aneurysm Embolization system from early prototype to broad adoption in the European market. Sequent was acquired by Terumo Corporation in July 2016 for $380 million. Prior to Sequent, Drew spent 11 years at Medtronic. His roles at Medtronic included the VP of Marketing for the AF Solutions business, VP of Clinical and Regulatory for the AF Solutions business and Director of Investor Relations. Drew also spent three years on an expatriate assignment in Europe leading the launch of Medtronic’s first drug eluting coronary stent. Prior to Medtronic, he spent four years at ABN AMRO bank in Chicago focused on healthcare transactions. He earned a B.B.A. in Finance from the University of Wisconsin and an MBA from Harvard Business School.
Mitch Hill

Mitch Hill

Chief Financial Officer
Mitch has extensive experience leading financial functions at both large and small companies. With senior executive experience at a number of private equity and venture capital-backed companies in medical device and health care services, Mitch has led many organizations to scale their financial strategies during rapid growth, such as Cameron Health which was acquired by BSX and Visiogen which was acquired by ABT. Prior to entering the health care industry, served as CFO of Walt Disney Imagineering and as President and CFO of Buy.com, Inc., including at the time of its initial public offering in February 2000. Mitch brings a wealth of financial knowledge and experience from high growth industries and an understanding of the challenges and landscape of modern healthcare. He earned a BS in Accounting from Brigham Young Univ. and an MBA from Harvard Business School.
Dr. Thomas Tu

Dr. Tom Tu

Chief Medical Officer
Dr. Thomas Tu joins Inari Medical after practicing Interventional Cardiology for 16 years. He is a graduate of Harvard Medical School and completed residency at Massachusetts General Hospital. He was trained in Interventional Cardiology, Peripheral Vascular Intervention, and Structural Heart Disease at Beth Israel Deaconess Medical Center. Most recently, he was the Cath Lab director and leader of the Pulmonary Embolism, complex PCI, and TAVR programs at Baptist Health Louisville. Dr. Tu helped develop the early phase technology that allowed Inari Medical to optimize patient outcomes. He also served as the presenter for the FLARE IDE trial of the Inari FlowTriever Retrieval/Aspiration System. This study led to FDA 510 (k) clearance for treatment of pulmonary embolism, the first thrombectomy device cleared for that indication.

Senior Management

Paul Koehn

Paul Koehn

Vice President of Operations
Paul brings to Inari over 25 years of experience in high volume, high quality growth operations across multiple industries. With experience both in domestic and global strategic planning, Paul’s work in product development and production has resulted in 4 revolutionary device platforms and 150 total products. Paul has a excellent track record in overall business performance exceeding 80% gross margin on all products, 92% gross margin on devices, and established scalable production and distribution capacity to greater than 4 times demand. In addition, Paul also brings a understanding of construction of manufacturing facilities and corporate offices. Paul was most recently the Senior Vice President of Quality and Operations at Cardiovascular Systems Inc. where he was crucial in the growth of the company from $0 revenue in 2007 to over $200M in 2017.
Tara Dunn

Tara Dunn

Vice President of Clinical Affairs and Market Development
Tara has extensive multi-functional medical device experience across a range of start-ups and larger organizations. Her most recent role was as the Venous Business Segment Leader at Volcano Corporation, acquired by Philips in 2015. Tara’s venous business experienced explosive triple digit growth in her time at the helm. Prior to Philips Volcano, she worked at Medtronic in Corporate Development where she participated in numerous transactions including the ~$816M acquisition of Kanghui Holdings in China and the divestiture of its Physio-Control business unit to Bain Capital for $487M. Tara also worked as a project leader at a healthcare strategy consulting firm called Health Advances and as Manager, Clinical and Regulatory Affairs at InfraReDx. She earned an A.B. in Biology from Harvard University, a M.S. in Regulatory Affairs and Health Policy from the Massachusetts College of Pharmacy and a M.B.A from Harvard Business School. Tara was a member of the National Championship winning ice hockey team and Ivy league championship team in softball while at Harvard. She also went on to compete in the National Women’s Hockey League (NWHL) for two seasons.
John Borrell

John Borrell

Vice President of Sales
John brings over 25 years of extensive commercial experience with early stage and mature medical device companies. His most recent roles were VP of Global Sales and Marketing at Trireme Medical and Area VP of Sales at Medtronic/Covidien Venous Vascular. Prior to that he was VP of Sales and Marketing at Cardiovascular Systems Inc. (CSI), where he created/executed the commercial strategy driving revenue growth from $5M to $43M in year 1 of commercial launch. Prior to CSI, John was the US Director of Sales at Fox Hollow Technologies where he played an integral role in the aggressive revenue ramp in their early commercial years. Other successful start up’s that he was a part of prior to Fox Hollow: Novoste Corporation, Arterial Vascular Engineering and Heartport Inc. John earned his Bachelor of Science in Business Marketing from the University of Massachusetts at Lowell where he played Division 1 college hockey for four years.
Brian Strauss

Brian Strauss

Vice President of Engineering
Brian joined Inari in April 2017. Brian has an extensive background in development of novel and disruptive medical device technologies in early stage companies, consistently resulting in value creation and successful exits. He has held senior executive positions in R&D, operations, and IP development. Prior to joining Inari, Brian was Chief Technology Officer at Reverse Medical, Inc. where he was responsible for developing neurovascular catheters and devices, one of which was sold to Covidien in 2012, the others of which were sold to Medtronic as part of their acquisition of Reverse in 2014. Brian remained at Medtronic as R&D Director of their neurovascular division responsible for embolization product development. Before Reverse Medical, Brian held management and engineering positions at ev3 (acquired by Covidien), Micro Therapeutics (acquired by ev3), and Gish Biomedical (acquired by Sorin Medical). Brian holds a B.S. in mechanical engineering from the University of California, Santa Barbara, and a Masters of Business Administration from California State University, Long Beach. Brian is a named inventor on over 50 issued U.S. and international patents.
Eric Khairy

Eric Khairy

Vice President of Marketing
Eric holds over 15 years of medical device experience in marketing, sales, strategy, and product development. Following the acquisition of Volcano by Philips in 2016, Eric progressed from leading global peripheral venous marketing to driving strategy of the peripheral vascular segment at Philips Image-Guided Therapy Devices. Joining Corindus Vascular Robotics in the company’s pre-commercial phase in 2012, Eric launched the first FDA cleared robotic-assisted system for percutaneous coronary interventions. Prior to Corindus, Eric led Intuitive Surgical’s launch and distribution of the da Vinci Surgical System in the Canadian market at Minogue Medical. Eric earned a B.Eng. in computer engineering from McGill University, an M.A.Sc. in biomedical engineering from the University of Montreal, and an MBA from the Sloan School of Management at MIT.
Justin Crockett

Justin Crockett

VP, Inari Solutions Group, Medical Affairs

Justin Crockett joined Inari Medical in November 2020 as Vice president of Inari Solutions Group and brings with him over 20 years of marketing, clinical, and commercial management experience. Justin joined Inari Medical from Boston Scientific, where he served as Vice President of U.S. Healthcare Solutions leading commercial solutions across the Cardiac Rhythm Management Division and the Interventional Cardiology Group. Prior to Boston Scientific, Justin served in multiple sales and marketing roles with St. Jude Medical (acquired by Abbott) and Pfizer Pharmaceuticals. Justin holds a Bachelor of Business Administration from the University of Mississippi, an MBA from the University of Southern Mississippi, and a doctorate degree from the Medical University of South Carolina. Justin also is a Lecturer of Health Administration at New York University.

Vitas Sipelis

Vitas Sipelis

VP, International

Vitas brings nearly 20 years of medical device sales and marketing expertise to Inari. Prior to joining Inari Vitas spent 14 years with Medtronic’s Neurovascular business. He joined that business when it was a small start-up called Micro Therapeutics, and grew with the organization as it became ev3, Covidien, and eventually, Medtronic. From 2006 on, he held multiple Marketing roles of increasing responsibility and launched its pivotal Acute Ischemic Stroke platform globally. In 2014 Vitas moved to Singapore, where under Covidien he led the Marketing organization for Vascular Therapies across Asia. In 2016, under Medtronic, Vitas became the General Manager for the Neurovascular business across Asia Pacific. Prior to his Neurovascular experience Vitas spent time with Applied Medical in the laparoscopic surgery arena and other start-up biotechnology ventures. Vitas holds a B.A in Political Science and History from McGill University, and an MBA from the University of California, Irvine.

Eric Louw

Eric Louw

VP, Manufacturing

Eric has more than 18 years of medical device experience, holding various positions in manufacturing, manufacturing support, engineering, and leadership. Eric has a proven record of scaling new products to high volume output with world-class quality and reliability, as well as developing and maintaining a robust product supply chain. Prior to joining Inari in 2014, Eric held several engineering positions at SenoRx Inc. and Bard Peripheral Vascular (which acquired SenoRx in 2010).

Janet Byk

Janet Byk

VP, Finance & Accounting

Janet joined Inari Medical as an Outsourced Controller in March of 2015. Bringing over 25 years of financial knowledge and expertise, Janet was promoted to Senior Director of Finance and Accounting in March of 2019, leading all aspects of the financial transaction and reporting processes. Prior to joining Inari Medical, Janet founded Byk & Associates, Inc., serving as an outsourced controller for life science start-ups in Orange County for 17 years, after spending 10 years in EY’s audit practice. She earned a BS in Accounting from California State University-Long Beach - College of Business and is a Certified Public Accountant.

Angela Ahmad

Angela Ahmad

General Counsel

Angela has over 20 years of public company legal experience. Prior to joining Inari, Angela served as the Deputy General Counsel of CoreLogic, Inc., where she held various roles including overseeing the corporate governance, M&A and securities functions. Angela also served as a senior associate at Latham & Watkins, LLP and Fried Frank, where she advised clients on corporate transactions, including equity and debt financings. Her private practice experience included five years in London, England during which time she advised corporate and investment banking clients on financing transactions. She earned a BA in French from Stetson University and a JD from the University of Florida.

Kevin Strange

Kevin Strange

VP, Strategy and Business Development

Kevin brings over 15 years of medical device experience in corporate development (M&A and venture capital), strategy, finance and sales. Most recently, Kevin was the Director of Business Development for the Peripheral Interventions division of Boston Scientific, where he helped transform the business from $1B of annual sales to over $1.7B. Kevin’s deal experience spans multiple acquisitions, divestitures and venture investment transactions, including the $4.2B acquisition of BTG and the $160M acquisition of Veniti. Prior to Boston Scientific, Kevin worked as an equity research analyst at Wells Fargo Securities and Bank of America Merrill Lynch covering the medical device sector. Kevin started his career in medical devices in the Cardiac Rhythm Management division of Medtronic. Kevin holds a BS in Biology from Davidson College and a Masters of Business Administration from New York University’s Stern School of Business.